rs764330616
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_004006.3(DMD):āc.7397T>Cā(p.Met2466Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000438 in 1,208,880 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 22 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_004006.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMD | ENST00000357033.9 | c.7397T>C | p.Met2466Thr | missense_variant | 51/79 | 1 | NM_004006.3 | ENSP00000354923.3 |
Frequencies
GnomAD3 genomes AF: 0.0000450 AC: 5AN: 111081Hom.: 0 Cov.: 21 AF XY: 0.0000902 AC XY: 3AN XY: 33255
GnomAD3 exomes AF: 0.000109 AC: 20AN: 183193Hom.: 0 AF XY: 0.000133 AC XY: 9AN XY: 67725
GnomAD4 exome AF: 0.0000437 AC: 48AN: 1097741Hom.: 0 Cov.: 30 AF XY: 0.0000523 AC XY: 19AN XY: 363121
GnomAD4 genome AF: 0.0000450 AC: 5AN: 111139Hom.: 0 Cov.: 21 AF XY: 0.0000900 AC XY: 3AN XY: 33323
ClinVar
Submissions by phenotype
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 24, 2019 | The p.Met2466Thr variant in DMD is classified as likely benign because it has been identified in 0.09% (17/19070) of South Asian chromosomes, including 9 hemizygotes, by gnomAD (http://gnomad.broadinstitute.org). Computational prediction tools and conservation analysis suggest that this variant may not impact the protein. ACMG/AMP Criteria applied: BS1, BP4. - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 25, 2017 | - - |
Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | May 08, 2018 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Duchenne muscular dystrophy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 09, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at